Yannick Adler
Biography
Overview
Yannick is a partner in White & Case's Global Capital Markets Practice.
Yannick advises clients, including banks, private equity houses and major corporations, on high-yield bond offerings, public and private debt and equity transactions (including liability management transactions) as well as mergers, acquisitions and related corporate transactions. He also has significant experience in other debt finance as well as restructuring transactions.
Prior to joining White & Case, Yannick worked for a renowned US law firm in New York and London, with a particular focus on capital markets transactions, including cross border high yield debt and equity offerings, and mergers and acquisitions.
Experience
Advised Adler Group S.A. and its subsidiaries on its successful restructuring, which included amendments to the terms and conditions of certain of its bonds with an aggregate nominal amount of €3.2 billion and the provision of up to €937.5 million of new money funding.
Advised on high-yield debt offerings (representing either the initial purchasers or the issuer) of Benteler Group, Braas Monier, Burford Capital Limited, Dufry, Consolidated Energy Finance S.A. (a Proman subsidiary), Hess Midstream Partners, Jewel UK Bondco (an Apollo Global Management special purpose vehicle), Lowell, Löwen Play, Platin 1426. (a Blackstone special purpose vehicle), PrestigeBidCo (a Permira debt vehicle), Rossini (a CVC Capital Partners debt vehicle), Vista Outdoor and Yell.
Advised on term loan financings of Consolidated Energy Finance S.A. (a Proman subsidiary) and Delivery Hero SE.
Advised on investment grade debt offerings (representing either the underwriters or the issuer) of AXIS, Baker Hughes, Enstar, KLA-Tencor, Level 3, Naspers, Prosus and Uniti.
Advised on IPOs for Deutsche Pfandbriefbank, innogy and Knorr-Bremse, and other equity offerings for HDFC Bank and Kion.
Advised Linde on its $70 billion merger of equals with Praxair.
Advised Naspers on a share exchange transaction with Ctrip.com.
Advised Novartis on the $29.8 billion spin-off of Alcon.
* Certain experience prior to joining White & Case.
